Woolfenden J M, Alberts D S, Hall J N, Patton D D
Cancer. 1979 May;43(5):1652-7. doi: 10.1002/1097-0142(197905)43:5<1652::aid-cncr2820430514>3.0.co;2-i.
Cobalt-57 bleomycin imaging was performed in 11 patients with a history of head and neck cancer. Clinical and scan findings concurred on the presence and extent of tumor in 9 patients (82%); tumor was present in 7 and absent in 2 of the 9. In 2 patients (18%) the scan demonstrated tumor in the neck but failed to show metastatic sites. Cobalt-57 bleomycin images were of good technical quality, with remarkably low background activity at 24 hours after administration. Cobalt-57 bleomycin imaging appears to be a promising technique for evaluating patients with head and neck tumors.
对11例有头颈癌病史的患者进行了钴-57博来霉素显像。临床和扫描结果在9例患者（82%）中对肿瘤的存在和范围达成一致；9例中有7例存在肿瘤，2例不存在。2例患者（18%）扫描显示颈部有肿瘤，但未显示转移部位。钴-57博来霉素图像技术质量良好，给药后24小时背景活性极低。钴-57博来霉素显像似乎是评估头颈肿瘤患者的一种有前景的技术。
